NCT00654758 2017-11-21
A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)
AbbVie
Phase 1 Completed
Clinical Trials
4 trialsNCT00401570 2013-01-30
A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer
AbbVie
Phase 2 Completed
NCT00100685 2012-04-27
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)
Abbott
Phase 2 Terminated
NCT00666692 2012-04-27
A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)
Abbott
Phase 1 Completed